Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Shapiro

Showing results (21-30 of 413) with videos related to

Pageof 42
Sort By:
Current Opinion in Cardiology|June 28, 2019
Future role of proprotein convertase subtilisin/kexin type 9 inhibitors in preventive cardiologyTahir Mahmood, Michael D Shapiro
F1000Research|March 17, 2017
Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular diseaseMichael D Shapiro, Sergio Fazio
Journal of Atherosclerosis and Thrombosis|March 18, 2017
PCSK9 and Atherosclerosis - Lipids and BeyondMichael D Shapiro, Sergio Fazio
US Cardiology|December 25, 2024
Current Evidence and Future Directions of PCSK9 InhibitionJiaqian Xu, Michael D Shapiro
Transactions of the American Clinical and Climatological Association|July 18, 2020
PREVENTIVE CARDIOLOGY AS NEW SUBSPECIALTY OF CARDIOVASCULAR MEDICINESergio Fazio, Michael D Shapiro
Plos One|October 13, 2020
Coronary artery calcium testing in low-intermediate risk symptomatic patients with suspected coronary artery disease: An effective gatekeeper to further testing?Tahir Mahmood, Michael D Shapiro
Circulation Research|July 22, 2017
Setting the Agenda for Preventive CardiologyMichael D Shapiro, Sergio Fazio
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 25, 2018
PREDICTING HYPERTRIGLYCERIDEMIC PANCREATITIS - NOT SO FAST!Michael D Shapiro, Sergio Fazio
Journal of Cardiopulmonary Rehabilitation and Prevention|November 7, 2022
Assessment of Atherosclerotic Cardiovascular Disease Risk in Primary PreventionRishi Rikhi, Michael D Shapiro
The Journal of Family Practice|June 22, 2019
Translating AHA/ACC cholesterol guidelines into meaningful risk reductionCezary Wójcik, Michael D Shapiro
Pageof 42

Showing results (21-30 of 413) with videos related to

Sort By:
Pageof 42
Current Opinion in Cardiology|June 28, 2019
Future role of proprotein convertase subtilisin/kexin type 9 inhibitors in preventive cardiologyTahir Mahmood, Michael D Shapiro
F1000Research|March 17, 2017
Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular diseaseMichael D Shapiro, Sergio Fazio
Journal of Atherosclerosis and Thrombosis|March 18, 2017
PCSK9 and Atherosclerosis - Lipids and BeyondMichael D Shapiro, Sergio Fazio
US Cardiology|December 25, 2024
Current Evidence and Future Directions of PCSK9 InhibitionJiaqian Xu, Michael D Shapiro
Transactions of the American Clinical and Climatological Association|July 18, 2020
PREVENTIVE CARDIOLOGY AS NEW SUBSPECIALTY OF CARDIOVASCULAR MEDICINESergio Fazio, Michael D Shapiro
Plos One|October 13, 2020
Coronary artery calcium testing in low-intermediate risk symptomatic patients with suspected coronary artery disease: An effective gatekeeper to further testing?Tahir Mahmood, Michael D Shapiro
Circulation Research|July 22, 2017
Setting the Agenda for Preventive CardiologyMichael D Shapiro, Sergio Fazio
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 25, 2018
PREDICTING HYPERTRIGLYCERIDEMIC PANCREATITIS - NOT SO FAST!Michael D Shapiro, Sergio Fazio
Journal of Cardiopulmonary Rehabilitation and Prevention|November 7, 2022
Assessment of Atherosclerotic Cardiovascular Disease Risk in Primary PreventionRishi Rikhi, Michael D Shapiro
The Journal of Family Practice|June 22, 2019
Translating AHA/ACC cholesterol guidelines into meaningful risk reductionCezary Wójcik, Michael D Shapiro
Pageof 42